KAYLUNRIE

Serial Number 98253768
730

Registration Progress

Application Filed
Nov 3, 2023
Under Examination
Sep 10, 2024
Approved for Publication
Jul 16, 2024
Published for Opposition
Jul 16, 2024
Registered

Trademark Image

KAYLUNRIE

Basic Information

Serial Number
98253768
Filing Date
November 3, 2023
Published for Opposition
July 16, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Feb 4, 2025
Application
Pending
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46825

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Legal Representation

Attorney
Bruce W. Longbottom

Application History

14 events
Date Code Type Description Documents
Feb 5, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 4, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 4, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 4, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 10, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 16, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 16, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 16, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 16, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 26, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 12, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 12, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 21, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 7, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Classification

International Classes
005